These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6224124)

  • 41. Mecillinam alone and in combination with ampicillin or moxalactam in experimental Escherichia coli meningitis.
    Schaad UB; Grimm LM; Beskid G; Cleeland R; Nelson JD; McCracken GH
    Infection; 1982; 10(2):90-6. PubMed ID: 6284652
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Septicemia and focal infection. Efficacy of moxalactam. Results of the cooperative study conducted in France].
    Carbon C
    Sem Hop; 1983 Jun; 59(26):1981-4. PubMed ID: 6310791
    [No Abstract]   [Full Text] [Related]  

  • 43. [Treatment of enterobacterial meningitis in adults with intravenous lamoxactam].
    Wolff M; Regnier B; Decazes JM; Meulemans A; Witchitz JL; Vachon F
    Presse Med; 1983 Mar; 12(10):615-9. PubMed ID: 6220282
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics of cefoperazone, moxalactam, cefotaxime, trimethoprim and sulphamethoxazole in experimental meningitis.
    Perfect JR; Durack DT
    J Antimicrob Chemother; 1981 Jul; 8(1):49-58. PubMed ID: 6265429
    [No Abstract]   [Full Text] [Related]  

  • 45. [Moxalactam (lamoxactam)].
    Hofstetter A
    Urologe A; 1982 Jul; 21(4):239-40. PubMed ID: 6215756
    [No Abstract]   [Full Text] [Related]  

  • 46. Absorption, excretion, and clinical efficacy of moxalactam in pediatric patients.
    Fujii R
    Rev Infect Dis; 1982; 4 Suppl():S656-63. PubMed ID: 6218579
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Moxalactam in the treatment of pediatric infections.
    Yogev R; Schreiber M; Gardner S; Shulman ST
    Am J Dis Child; 1982 Sep; 136(9):836-9. PubMed ID: 6214182
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical evaluation of moxalactam in the treatment of respiratory tract infections, hepatobiliary infections, and septicemia.
    Saito A
    Rev Infect Dis; 1982; 4 Suppl():S623-8. PubMed ID: 6218575
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Moxalactam versus gentamicin-clindamycin in surgical sepsis. Efficacy and safety.
    Stone HH; Kolb L; Geheber CE
    Schweiz Rundsch Med Prax; 1983 Mar; 72(11):351-5. PubMed ID: 6221242
    [No Abstract]   [Full Text] [Related]  

  • 50. [The French experience with moxalactam in pneumology].
    Leng B; Imbert Y; Coomans D
    Sem Hop; 1983 Jun; 59(26):1977-80. PubMed ID: 6310790
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Moxalactam.
    Lancet; 1981 Jul; 2(8236):23-4. PubMed ID: 6113400
    [No Abstract]   [Full Text] [Related]  

  • 52. [Clinical studies of 6059-S in the field of pediatrics (author's transl)].
    Minamitani M; Hachimori K; Tomori N
    Jpn J Antibiot; 1981 Apr; 34(4):608-17. PubMed ID: 6457169
    [No Abstract]   [Full Text] [Related]  

  • 53. [Clinical experience with moxalactam in the treatment of mixed aerobic-anaerobic surgical infections].
    Gonzenbach HR; Sonnabend W
    Schweiz Rundsch Med Prax; 1983 Mar; 72(11):356-62. PubMed ID: 6221243
    [No Abstract]   [Full Text] [Related]  

  • 54. [Clinical studies on 6059-S in pediatric field (author's transl)].
    Nagata K; Fujita M; Haneda S; Aoyama R; Izumi Y
    Jpn J Antibiot; 1981 Apr; 34(4):558-61. PubMed ID: 6457164
    [No Abstract]   [Full Text] [Related]  

  • 55. [Clinical results of latamoxef on pertussis].
    Minamitani M; Hachimori K; Nakazawa S; Sato H; Narita A; Hirama Y; Nakazawa S; Chikaoka H; Motohiro T; Nishiyama T; Fujimoto T; Ishimoto K; Tominaga K; Yamashita F; Matsuo H; Koga Y; Eto Y; Matsuyuki M; Yuasa T; Tanaka Y; Nagayama K; Shimada Y; Aramaki S; Takajo N; Araki H; Kawano Y
    Jpn J Antibiot; 1983 Feb; 36(2):233-40. PubMed ID: 6304367
    [No Abstract]   [Full Text] [Related]  

  • 56. Treatment of serious infections with moxalactam.
    Ribner BS; Raeder R; Becker TM; Freimer EH
    Am J Med; 1983 Mar; 74(3):396-400. PubMed ID: 6219576
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Moxalactam therapy for bacterial pneumonia.
    Perlino CA
    Rev Infect Dis; 1982; 4 Suppl():S617-22. PubMed ID: 6218574
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical evaluation of moxalactam.
    Livingston WK; Elliott AM; Dismukes WE; Avent CK; Cobbs CG
    Antimicrob Agents Chemother; 1981 Jul; 20(1):88-97. PubMed ID: 6456688
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetics and clinical efficacy of moxalactam in biliary tract infections.
    Mueller O; Fabricius K; Krueger E; Rueckert U
    Rev Infect Dis; 1982; 4 Suppl():S688-91. PubMed ID: 6218584
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Penetration of cefotaxime and moxalactam into cerebrospinal fluid of rabbits with experimentally induced Escherichia coli meningitis.
    Nolan CM; Ulmer C
    Rev Infect Dis; 1982; 4 Suppl():S396-400. PubMed ID: 6294789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.